Zydus Lifesciences share price advanced over 5 percent in trade today after the company announced an agreement with US healthcare firm CVS Caremark to add its diabetes combination products to…

Be the first to know the latest updates
Whoops, you're not connected to Mailchimp. You need to enter a valid Mailchimp API key.